Immunotherapy Breakthroughs for Hard-to-Treat Tumors

Immunotherapy harnesses the body's own immune system to recognize and destroy cancer cells, offering new hope where conventional therapies have fallen short. Researchers are continuously discovering new checkpoint inhibitors and combination therapies to overcome tumor resistance.

Funding dedicated to immunotherapy research allows laboratories to test groundbreaking hypotheses. We are committed to backing projects that expand the boundaries of how the human immune system can fight back against aggressive malignancies.

Source: Backed by clinical trials and updates compiled by the National Cancer Institute (NCI) regarding immune checkpoint inhibitors (ICIs) and adjuvant treatments for lung cancer.